Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 4
2016 3
2017 6
2018 11
2019 4
2020 4
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Metro G, Gariazzo E, Costabile S, Baglivo S, Roila F, Colamartini F, Palumbo B, Chiarini P, Gori S, Conti A, Marcomigni L, Bellezza G, Lunardi G. Metro G, et al. Among authors: baglivo s. Oncol Ther. 2024 Mar;12(1):173-174. doi: 10.1007/s40487-023-00258-z. Oncol Ther. 2024. PMID: 38170387 Free PMC article. No abstract available.
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Metro G, Gariazzo E, Costabile S, Baglivo S, Roila F, Colamartini F, Palumbo B, Chiarini P, Gori S, Conti A, Marcomigni L, Bellezza G, Lunardi G. Metro G, et al. Among authors: baglivo s. Oncol Ther. 2024 Mar;12(1):163-171. doi: 10.1007/s40487-023-00251-6. Epub 2023 Nov 16. Oncol Ther. 2024. PMID: 37973688 Free PMC article.
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Mandalà M, Palmieri G, Ludovini V, Baglivo S, Marasciulo F, Castiglione F, Gili A, Osella Abate S, Rubatto M, Senetta R, Avallone G, Ribero S, Romano L, Pimpinelli N, de Giorgi V, Roila F, Pisano M, Casula M, Manca A, Sini MC, Massi D, Quaglino P; Italian Melanoma Intergroup (IMI). Mandalà M, et al. Among authors: baglivo s. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):1991-1998. doi: 10.1111/jdv.19281. Epub 2023 Jun 27. J Eur Acad Dermatol Venereol. 2023. PMID: 37335879
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Canale M, Petracci E, Cravero P, Mariotti M, Minuti G, Metro G, Ludovini V, Baglivo S, Puccetti M, Dubini A, Martinelli G, Delmonte A, Crinò L, Ulivi P. Canale M, et al. Among authors: baglivo s. Transl Oncol. 2022 Sep;23:101471. doi: 10.1016/j.tranon.2022.101471. Epub 2022 Jun 29. Transl Oncol. 2022. PMID: 35779323 Free PMC article.
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
Baglivo S, Mandarano M, Bellezza G, Minotti V, Bonaiti A, Fischer MJ, Birocchi I, Roila F, Metelli N, Ludovini V, Metro G. Baglivo S, et al. Oncol Ther. 2022 Jun;10(1):291-300. doi: 10.1007/s40487-022-00183-7. Epub 2022 Jan 23. Oncol Ther. 2022. PMID: 35066813 Free PMC article.
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.
Baldelli E, El Gazzah E, Moran JC, Hodge KA, Manojlovic Z, Bassiouni R, Carpten JD, Ludovini V, Baglivo S, Crinò L, Bianconi F, Dong T, Loffredo J, Petricoin EF, Pierobon M. Baldelli E, et al. Among authors: baglivo s. Genes (Basel). 2021 Sep 11;12(9):1402. doi: 10.3390/genes12091402. Genes (Basel). 2021. PMID: 34573384 Free PMC article.
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
Metro G, Baglivo S, Bellezza G, Mandarano M, Gili A, Marchetti G, Toraldo M, Molica C, Reda MS, Tofanetti FR, Siggillino A, Prosperi E, Giglietti A, Di Girolamo B, Garaffa M, Marasciulo F, Minotti V, Gunnellini M, Guida A, Sassi M, Sidoni A, Roila F, Ludovini V. Metro G, et al. Among authors: baglivo s. Genes (Basel). 2021 Apr 30;12(5):679. doi: 10.3390/genes12050679. Genes (Basel). 2021. PMID: 33946594 Free PMC article.
41 results